Vir Biotechnology Inc (VIR)

EBITDA Growth

51.38%

TTM · Period ending:

VIR logo

VIR EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported51.38%
VIR TTM EBITDA YoY % (-47.96% → 51.38%)
High-resolution chart · PNG

VIR ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vir Biotechnology Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
51.3817%
20.9461%
10.313%
3.2162%
-12.0247%
0.788%
17.1496%
18.9915%
-83.1347%
-104.0118%
-172.3739%
-141.2659%
-120.0265%
-117.3359%
87.3966%
787.471%
573.4604%
535.6063%
260.3214%
2.9054%
-44.073%
-82.5301%
-66.7968%
-72.5526%
-58.6822%
-75.2093%
-47.964%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.